Point72 Hong Kong’s Ironwood Pharmaceuticals IRWD Stock Holding History

Point72 Hong Kong’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,987	Closed	-$352K	–	861
2022 Q3	$352K	Buy	+33,987	New	+$385K	0.01%	881
2022 Q2	–	Sell	-4,540	Closed	-$57K	–	2162
2022 Q1	$57K	Sell	4,540 -16,489	-78%	-$189K	﹤0.01%	1304
2021 Q4	$245K	Buy	21,029 +17,708	+533%	+$217K	0.01%	965
2021 Q3	$43K	Buy	+3,321	New	+$42.9K	﹤0.01%	1556
2020 Q2	–	Sell	-5,556	Closed	-$56K	–	1278
2020 Q1	$56K	Buy	+5,556	New	+$65.3K	0.02%	320
2019 Q2	–	Sell	-404	Closed	-$5K	–	1256
2019 Q1	$5K	Buy	404 +89	+28%	+$994	﹤0.01%	816
2018 Q4	$3K	Buy	315 +80	+34%	+$918	﹤0.01%	692
2018 Q3	$4K	Buy	+235	New	+$3.71K	﹤0.01%	723
2017 Q3	–	Sell	-823	Closed	-$13K	–	918
2017 Q2	$13K	Buy	+823	New	+$12K	0.01%	434

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Hong Kong's IRWD Position: Q4 2022 in Review

Point72 Hong Kong sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 33,987 shares — an estimated $352K sold.

Point72 Hong Kong first reported a position in IRWD in Q2 2017 and held it in 9 quarters. The position peaked at $352K in Q3 2022. 250 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

Point72 Hong Kong reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 33,987 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $352K.
Point72 Hong Kong first reported a position in Ironwood Pharmaceuticals in Q2 2017 and held it in 9 quarters.
Point72 Hong Kong's Ironwood Pharmaceuticals position peaked at $352K in Q3 2022.
250 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.